# OMCAZIO
> **NDA220613** · New Drug Application · Sponsor: HANDA ONCOL · Approved 2026-09-03
## Drug
- **FDA Application Number:** NDA220613
- **Application type:** New Drug Application
- **Brand name:** OMCAZIO
- **Generic name:** Cabozantinib Laurylsulfate
- **Active ingredients:** CABOZANTINIB LAURYLSULFATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HANDA ONCOL
- **First approval:** 2026-09-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220613)
---
*MORVS · CC0 1.0*